Lipum AB (publ)
STO: LIPUM.ST0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Stockholm Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Ola Sandborgh
- Employees
- 5
- Headquarters
- Umeå, Sweden
- IPO year
- 2021
- Market cap
- SEK 304.4M
- Website
- https://www.lipum.se
Loading LIPUM…
Loading profile data…Frequently asked questions about LIPUM
What does Lipum AB (publ) (LIPUM.ST) do?
Lipum AB (publ), a biopharmaceutical company, engages in the discovery and development of treatment for chronic inflammatory diseases in Sweden. It is developing SOL-116, a humanized antibody that is in late preclinical phase for the treatment of pediatric rheumatism and rheumatoid arthritis diseases. Lipum AB (publ) has a collaboration with Pel...
Where does LIPUM.ST trade?
Lipum AB (publ) (LIPUM.ST) trades on the Stockholm Stock Exchange.
What sector is LIPUM.ST in?
Lipum AB (publ) (LIPUM.ST) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Lipum AB (publ)?
Ola Sandborgh is the chief executive officer of Lipum AB (publ) (LIPUM.ST).
Where is Lipum AB (publ) headquartered?
Lipum AB (publ) is headquartered in Sweden.
Does LIPUM.ST pay a dividend?
Lipum AB (publ) (LIPUM.ST) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did LIPUM.ST go public?
Lipum AB (publ) (LIPUM.ST) completed its initial public offering in 2021.